Treatment Options Differ for Patients With Benign or Malignant Thyroid Cancer
In Partnership With
Winston Tan, MD, discusses the current treatment landscape for patients with thyroid cancer. He highlighted the importance of first determining if a patient with thyroid cancer has benign or malignant thyroid nodules, which can be identified with the use of diagnostic biopsies. He also discussed the standard-of-care treatment options for these different subtypes of patients once they are identified.
Winston Tan, MD, a hematologist/oncologist at the Mayo Clinic and vice president of the Florida Society for Clinical Oncology (FLASCO), discusses the current treatment landscape for patients with thyroid cancer. He highlighted the importance of first determining if a patient with thyroid cancer has benign or malignant thyroid nodules, which can be identified with the use of diagnostic biopsies. He also discussed the standard-of-care treatment options for these different subtypes of patients once they are identified.
The primary treatment for patients with thyroid cancer is surgery, Tan says. For patients that are diagnosed with benign and localized disease, they can receive a thyroidectomy. However, for patients with locally advanced thyroid cancer, it is appropriate to combine surgery with a radioactive iodine treatment.
Anticipating Novel Options for the RAI-Refractory DTC Armamentarium
May 15th 2023In season 4, episode 6 of Targeted Talks, Warren Swegal, MD, takes a multidisciplinary look at the RAI-refractory differentiated thyroid cancer treatment landscape, including the research behind 2 promising systemic therapy options.
Listen
